174 related articles for article (PubMed ID: 15765369)
1. Prevalence of diabetes mellitus in patients receiving depot neuroleptics or clozapine.
Miller MJ; Molla PM
Arch Psychiatr Nurs; 2005 Feb; 19(1):30-4. PubMed ID: 15765369
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
Brunero S; Lamont S; Fairbrother G
Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
[TBL] [Abstract][Full Text] [Related]
3. Metabolic screening in children receiving antipsychotic drug treatment.
Morrato EH; Nicol GE; Maahs D; Druss BG; Hartung DM; Valuck RJ; Campagna E; Newcomer JW
Arch Pediatr Adolesc Med; 2010 Apr; 164(4):344-51. PubMed ID: 20368487
[TBL] [Abstract][Full Text] [Related]
4. Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia.
Sernyak MJ; Gulanski B; Leslie DL; Rosenheck R
J Clin Psychiatry; 2003 May; 64(5):605-8. PubMed ID: 12755666
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications.
Hägg S; Joelsson L; Mjörndal T; Spigset O; Oja G; Dahlqvist R
J Clin Psychiatry; 1998 Jun; 59(6):294-9. PubMed ID: 9671341
[TBL] [Abstract][Full Text] [Related]
6. [Schizophrenia and diabetes mellitus: not an improbable combination].
Cohen D; Gispen-de Wied CC
Ned Tijdschr Geneeskd; 2003 May; 147(21):993-6. PubMed ID: 12811967
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus among parkinsonian patients treated chronically with clozapine.
Fernandez HH; Friedman JH; Lansang MC; Factor SA; Molho ES; Coskun DJ
Parkinsonism Relat Disord; 2004 Oct; 10(7):439-41. PubMed ID: 15465403
[TBL] [Abstract][Full Text] [Related]
8. [Diabetes mellitus after treatment with clozapine].
Brugman NJ; Cohen D; de Vries RH
Ned Tijdschr Geneeskd; 2000 Feb; 144(9):437-9. PubMed ID: 10719549
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia associated with the use of atypical antipsychotics.
Lindenmayer JP; Nathan AM; Smith RC
J Clin Psychiatry; 2001; 62 Suppl 23():30-8. PubMed ID: 11603883
[TBL] [Abstract][Full Text] [Related]
10. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
11. Frequency of new-onset diabetes mellitus and use of antipsychotic drugs among Central Texas veterans.
Barner JC; Worchel J; Yang M
Pharmacotherapy; 2004 Nov; 24(11):1529-38. PubMed ID: 15537558
[TBL] [Abstract][Full Text] [Related]
12. [Blood glucose in chronic schizophrenic patients treated with antipsychotics].
Wetterling T; Schneider B; Weber B
Psychiatr Prax; 2007 Mar; 34(2):76-80. PubMed ID: 17160751
[TBL] [Abstract][Full Text] [Related]
13. Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.
Sernyak MJ; Gulanski B; Rosenheck R
J Clin Psychiatry; 2005 Nov; 66(11):1463-7. PubMed ID: 16420085
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.
Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K
J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906
[TBL] [Abstract][Full Text] [Related]
15. The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.
Zhang R; Hao W; Pan M; Wang C; Zhang X; Chen DC; Xiu MH; Yang FD; Kosten TR; Zhang XY
Hum Psychopharmacol; 2011 Aug; 26(6):392-6. PubMed ID: 21826737
[TBL] [Abstract][Full Text] [Related]
16. [Diabetes mellitus type II--induced by "atypical" neuroleptics?].
Wetterling T
Fortschr Neurol Psychiatr; 2003 Jun; 71(6):312-22. PubMed ID: 12796851
[TBL] [Abstract][Full Text] [Related]
17. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.
Henderson DC; Cagliero E; Gray C; Nasrallah RA; Hayden DL; Schoenfeld DA; Goff DC
Am J Psychiatry; 2000 Jun; 157(6):975-81. PubMed ID: 10831479
[TBL] [Abstract][Full Text] [Related]
18. Clozapine: diabetes mellitus, weight gain, and lipid abnormalities.
Henderson DC
J Clin Psychiatry; 2001; 62 Suppl 23():39-44. PubMed ID: 11603884
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
[TBL] [Abstract][Full Text] [Related]
20. [Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].
Gutwinski S; Müller P; Koller M
Psychiatr Prax; 2007 Sep; 34(6):289-91. PubMed ID: 17806015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
